The Patent Finder
US

Individualized Vaccines for Cancer

US 10,155,031 In force
OverviewFamilyAssignmentsSources & methods

Term ends Nov 26, 2033 · High confidence

Held by BioNTech SE
Filed May 27, 2015 as application 14/647,577 · Granted Dec 18, 2018
Base term, 20 years from filing
Today
20 years from filing
2013 2033
Clock starts
Nov 26, 2013
Term ends
Nov 26, 2033
Granted
Dec 18, 2018
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Nov 26, 2013, when application PCT/EP2013/003559, the earliest non-provisional in its chain, was filed (this one was filed May 27, 2015)Nov 26, 2033High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderNov 26, 2033High confidence

Partial family

Application PCT/EP2013/003559PCT application
no patent term
no patent term
US 10,155,031this patent
Nov 2033
Nov 2033
US 11,504,419In force
Nov 2033
Nov 2033
US 12,642,844In force
Nov 2033
Nov 2033
Partial: 1 of the 4 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Dec 22, 2015
Reel 37349, frame 451
Paret, Claudia; Vormbrock, Kirsten; Bender, Christian; Diekmann, JanTron (Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Geminnutzige GmbH)Assignment of Assignor's Interest
Dec 22, 2015
Reel 37352, frame 120
Sahin, UgurBioNTech AG; Tron (Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Geminnutzige GmbH)Assignment of Assignor's Interest
Dec 22, 2015
reel/frame not recorded
Sahin, UgurBioNTech AGAssignment of Assignor's Interest
Dec 22, 2015
reel/frame not recorded
Sahin, UgurTron (Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Geminnutzige GmbH)Assignment of Assignor's Interest
Sep 21, 2016
Reel 39817, frame 212
BioNTech AGBioNTech Rna Pharmaceuticals GmbHAssignment of Assignor's Interest
May 26, 2017
Reel 42589, frame 116
Paret, Claudia; Vormbrock, Kirsten; Bender, Christian; Diekmann, JanTron (Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige GmbH)Corrective Assignment to Correct the Assignee's Name Previously Recorded on Reel 037349 Frame 0451. Assignor(S) Hereby Confirms the Assignment.
May 26, 2017
Reel 42589, frame 182
Sahin, UgurBioNTech AG; Tron (Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige GmbH)Corrective Assignment to Correct the Spelling of the Second Assignee's Name Previously Recorded on Reel 037352 Frame 0120. Assignor(S) Hereby Confirms the Assignment.
May 26, 2017
reel/frame not recorded
Sahin, UgurBioNTech AGCorrective Assignment to Correct the Spelling of the Second Assignee's Name Previously Recorded on Reel 037352 Frame 0120. Assignor(S) Hereby Confirms the Assignment.
May 26, 2017
reel/frame not recorded
Sahin, UgurTron (Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige GmbH)Corrective Assignment to Correct the Spelling of the Second Assignee's Name Previously Recorded on Reel 037352 Frame 0120. Assignor(S) Hereby Confirms the Assignment.
Nov 19, 2021
Reel 58215, frame 1
BioNTech Rna Pharmaceuticals GmbH; BioNTech SEBioNTech SEMerger and Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited